Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone

Clinical trial NCT00597428 · COMPLETED

Trial details

NCT number: NCT00597428
Sponsor: Sucampo Pharma Americas, LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Opioid-Induced Bowel Dysfunction

Start date: 2007-08-01
Primary completion: 2009-03-01
Enrollment: 437

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.